282 related articles for article (PubMed ID: 10096551)
21. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
22. The effect of intrauterine infusion of inflammation-provoking factors on proinflammatory cytokines and hormones in rat peripheral blood.
Jana B; Kucharski J; Jedlińska-Krakowska M; Wolińska-Witort E
Pol J Vet Sci; 2005; 8(4):275-82. PubMed ID: 16385851
[TBL] [Abstract][Full Text] [Related]
23. What regulates placental steroidogenesis in 90-day pregnant ewes?
Weems YS; Kim L; Tsuda V; Yin C; Weems CW
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
[TBL] [Abstract][Full Text] [Related]
24. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
[TBL] [Abstract][Full Text] [Related]
25. Effects of ethanol on leptin secretion and the leptin-induced luteinizing hormone (LH) release from late juvenile female rats.
Hiney JK; Dearth RK; Lara F; Wood S; Srivastava V; Les Dees W
Alcohol Clin Exp Res; 1999 Nov; 23(11):1785-92. PubMed ID: 10591595
[TBL] [Abstract][Full Text] [Related]
26. Targeted doxorubicin-containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers.
Bajo AM; Schally AV; Halmos G; Nagy A
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3742-8. PubMed ID: 14506166
[TBL] [Abstract][Full Text] [Related]
27. Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.
Szereday Z; Schally AV; Varga JL; Kanashiro CA; Hebert F; Armatis P; Groot K; Szepeshazi K; Halmos G; Busto R
Cancer Res; 2003 Nov; 63(22):7913-9. PubMed ID: 14633721
[TBL] [Abstract][Full Text] [Related]
28. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
29. Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment.
Christoffel J; Rimoldi G; Wuttke W
J Endocrinol; 2006 Mar; 188(3):397-405. PubMed ID: 16522720
[TBL] [Abstract][Full Text] [Related]
30. Prolonged decrease of serum calcium concentration by murine gamma-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice.
Sato K; Satoh T; Shizume K; Yamakawa Y; Ono Y; Demura H; Akatsu T; Takahashi N; Suda T
Cancer Res; 1992 Jan; 52(2):444-9. PubMed ID: 1728416
[TBL] [Abstract][Full Text] [Related]
31. Cessation of progesterone secretion by LH-RH in hypophysectomized pregnant and hypophysectomized, prolactin injected pseudopregnant rats.
Macdonald GJ; Greeley LK; Beattie CW
Int J Fertil; 1980; 25(3):198-202. PubMed ID: 6108930
[TBL] [Abstract][Full Text] [Related]
32. Hypercalcemia and neoplasia. Biologic, biochemical, and ultrastructural studies of a hypercalcemia-producing Leydig cell tumor of the rat.
Rice BF; Roth LM; Cole FE; MacPhee AA; Davis K; Ponthier RL; Sternberg WH
Lab Invest; 1975 Oct; 33(4):428-39. PubMed ID: 52757
[TBL] [Abstract][Full Text] [Related]
33. Growth inhibition of estrogen-sensitive rat mammary tumors. Effect of an alpha-fetoprotein-secreting hepatoma.
Sonnenschein C; Ucci AA; Soto AM
J Natl Cancer Inst; 1980 May; 64(5):1147-52. PubMed ID: 6154169
[TBL] [Abstract][Full Text] [Related]
34. Effect of fish oil supplementation for two generations on changes of lymphocyte function induced by Walker 256 cancer cachexia in rats.
Folador A; de Lima-Salgado TM; Hirabara SM; Aikawa J; Yamazaki RK; Martins EF; de Oliveira HH; Pizatto N; Kanunfre CC; Peres CM; Fernandes LC; Curi R
Nutr Cancer; 2009; 61(5):670-9. PubMed ID: 19838941
[TBL] [Abstract][Full Text] [Related]
35. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER
Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551
[TBL] [Abstract][Full Text] [Related]
36. Osseous and intestinal compartments in the humoral hypercalcemia of malignancy associated to Walker 256 tumor in rats.
Torres R; de la Piedra C; Rapado A
Oncology; 1993; 50(2):148-52. PubMed ID: 8451038
[TBL] [Abstract][Full Text] [Related]
37. The impact of tumor growth on plasma homocysteine levels and tissue-specific DNA methylation in Walker-256 tumor-bearing rats.
Pryzimirska TV; Pogribny IP; Chekhun VF
Exp Oncol; 2007 Dec; 29(4):262-6. PubMed ID: 18199980
[TBL] [Abstract][Full Text] [Related]
38. Adhesion, chemotaxis, and aggregation of Walker carcinosarcoma cells in response to products of resorbing bone.
Magro C; Orr FW; Manishen WJ; Sivananthan K; Mokashi SS
J Natl Cancer Inst; 1985 Apr; 74(4):829-38. PubMed ID: 3857380
[TBL] [Abstract][Full Text] [Related]
39. Naringin inhibits tumor growth and reduces interleukin-6 and tumor necrosis factor α levels in rats with Walker 256 carcinosarcoma.
Camargo CA; Gomes-Marcondes MC; Wutzki NC; Aoyama H
Anticancer Res; 2012 Jan; 32(1):129-33. PubMed ID: 22213297
[TBL] [Abstract][Full Text] [Related]
40. Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats.
Kostenuik PJ; Orr FW; Suyama K; Singh G
Cancer Res; 1993 Nov; 53(22):5452-7. PubMed ID: 8221685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
